News - Zybrestat

Filter

Current filters:

Zybrestat

Popular Filters

OXiGENE says Zybrestat Ph III study not feasible; cuts workforce as part of restructuring

01-09-2011

California, USA biotech OXiGENE (Nasdaq: OXGN), a clinical-stage, company developing novel therapeutics…

BiotechnologyFinancialOncologyOphthalmicsResearchZybrestat

Back to top